Publié 31 Oct. 2024
Appel à projets clos
Willing to unlock the full value of your oncology innovation?
When applying to the MATWIN accelerating program, you will:
- Assess and increase the potential of your project in the discovery / preclinical development phase from MATWIN coaching process
- Obtain validation guidelines for your development plan (clinical strategy, indications, milestones, regulatory guidance etc.) from MATWIN International Board), experts in the field and KOLs
- Get ready for the investment phase thanks to numerous individual high added-value MATWIN coaching / mentoring sessions
- Optimize your partnership opportunities with biotechs / pharmas / investors
ELIGIBILITY
- Open to any European academic team or start-up working on oncology innovative projects
- Preclinical or early clinical stage with validated POC and defined IP
- Projects in the field of therapeutic, diagnostic, medical device, technological platform, AI tools
Apply before October 31, 2024